Close

Retail

IBI is present with a variety of products on the Italian pharmaceutical distribution market, from ethical drugs to over-the-counter drugs and vitamins, in various treatment areas, such as gastroenterology, liver disease, pain and inflammation, and infectivology.
These historical trademarks, which came about from research and development into original products, were recently joined by the Realsil and Realsil100D line of herbal products and vitamin supplement.
More info: www.realsil.it

OTC DRUGS, SOP AND SUPPLEMENTS

  • METEOSIM tablets
  • SIMETICONE IBI
  • EDEVEN C.M. GEL
  • REALSIL
  • REALSIL100D

GASTROENTEROLOGY

IBI has been present in gastroenterology since the 1970s with products for therapies correlated to stomach diseases, dyspepsia, liver diseases such as gallstones, cholelithiasis, cholestasis and other chronic liver diseases such fatty liver and steatohepatitis, as well as cures for gastrointestinal symptoms with products to improve intestinal symptoms, bloating and constipation.

ANTIBIOTIC TREATMENT

The traditional core business of the Istituto Biochimico Italiano is the production of pharmacologically active raw materials and ethical specialities, in particular in the field of antibiotic treatment. IBI is specialized in the production of injectable sterile penicillin, which is exported all over the world.

INFLAMMATION AND PAIN

In the treatment of pain symptoms and inflammation, IBI proposes a product based on ketoprofen, widely tested for efficacy and speed of action, offering a wide range of oral, injectable and topical formulations for doctors and patients’ requirements. Furthermore, in conditions of capillary fragility associated with oedema and minor traumas, IBI offers a product based on horse chestnut, whose efficacy has been the subject of various clinical trials in the last 30 years, especially in post-surgical oedema and post-traumatic oedema.


Search in the product catalogue

AMPICILLINA E SULBACTAM IBI

Antibiotici
Ampicillina+Sulbactam
CEFOTAXIME IBI

Pharmacotherapeutic group: Antiinfectives, cephalosporins - ATC Code: J01DD01

Antibiotici
Cefotaxime Sodico
CLINDAMICINA IBI

Pharmacotherapeutic group: antibacterials for systemic use. ATC code: J01FF01

Antibiotici
Clindamicina Fosfato
EDEVEN C.M. GEL

Pharmacotherapeutic group: drugs for topical use, for joint and muscular pain - ATC Code: M02AC

Infiammazione/Edema
Escina+Dietilamina Salicilato
EDEVEXIN

Pharmacotherapeutic group: vasoprotectors - capillaroprotective substances - ATC Code C05CX

Infiammazione/Edema
Escina
IBIFEN

Pharmacotherapeutic group: non-steroidal anti-inflammatory/antirheumatic drugs - ATC code: M01AE03Pharmacotherapeutic group: non-steroidal anti-inflammatory for topical use - ATC Code M02AA10

Infiammazione/Edema
Ketoprofene
IBITAZINA

Pharmacotherapeutic group: Antibacterials for systemic use. Association of penicillins and beta-lactamase inhibitors - ATC Code: J01CR05

Antibiotici
Piperacillina+Tazobactam
IBIXACIN

Pharmacotherapeutic group: Fluoroquinolones - ATC Code: J01MA02

Antibiotici
Ciprofloxacina
LAXIDO

Gastroenterelogica
Macrogol 3350+Sodio Cloruro+Sodio Idrogenocarbonato+Potassio Cloruro
METEOSIM

Pharmacotherapeutic group: other drugs for functional bowel disorders - ATC Code: A03AX13

Gastroenterelogica
Simeticone
PIPERITAL

Pharmacotherapeutic group: Antibacterials for systemic use - ATC Code: J01CA12

Antibiotici
Piperacillina
REALSIL ORO

Gastroenterelogica
Estratto di Cardo Mariano con Fosfolipidi e Vitamina E
REALSIL

Gastroenterelogica
Estratto di Cardo Mariano con Fosfolipidi e Vitamina E
SIMETICONE IBI

Pharmacotherapeutic group: other drugs for functional bowel disorders - ATC Code: A03AX13

Gastroenterelogica
Simeticone
TOBRAMICINA IBI

Pharmacotherapeutic group: antibacterials for systemic use - ATC Code: J01GB01

Antibiotici
Tobramicina
URSILON

Pharmacotherapeutic group: Preparations based on bile acids - ATC Code A05AA02

Gastroenterelogica
Acido Ursodesossicolico

Thank you

We sent you an email. To activate the newsletter click on the link you will find in the message, thank you!

Sign up for the newsletter


Dichiarazione in merito al GDPR (Regolamento Generale Protezione dei Dati)

In caso di sottoscrizione Newsletter dovrai confermare l’iscrizione per mezzo di mail di conferma inviata all’indirizzo inserito. In tal caso il trattamento prevede:

la profilazione dell’utente in gruppi, status, preferenze secondo quanto indicato e dedotto dalle informazioni inviate tramite il form o successiva autonoma profilazione.
l’utilizzo del dato per l’invio di comunicazione a mezzo digitale (email, whatsapp) e non (cartaceo) avente scopo informativo/commerciale.
l'utilizzo della mail per la generazione di campagne marketing e informative personalizzate, digitali e non.

Cancel
CHIUDI


Private area


Log in to restricted area


Registration


Notice on the treatment of personal data

Dear visitor, in the following sections we will describe how the reserved area of the www.ibi-lorenzini.it website is managed as far as processing personal data of users. The notice is issued pursuant to art. 13 of EU Regulation 679/2016 (hereinafter also the Regulation) on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and applies to those who interact with the website of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (hereinafter I.B.I.), which can be accessed at the following address: www.ibi-lorenzini.it, the opening page of the official I.B.I. website. The notice only applies to the I.B.I. website. It does not apply to any other websites that the user may access through links.

  1. The processing of the personal data that you supply, which are also used for the creation of your user profile, and which will be included in the “Doctors’ Details” database, has the following purposes:
  • carry out medical sales related activities for drugs for human consumption. Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. and Ibigen S.r.l., part of the same company group (hereinafter also Ibigen Group), carry out such activities in compliance with the provisions of the current regulations, with particular, but not exclusive, attention to Italian Legislative Decree no. 219 of 24.04.2006 and subsequent modifications. In view of the objectives of the Ibigen Group, it is important to point out that the processing activities do not deal with any special data. The supply of the data for the medical sales activities is necessary, and failure to provide consent will make it impossible for us to fulfil the above objectives;

  • forwarding of invitations or information on congresses, conferences, seminars, communications on initiatives promoted or sponsored by the Ibigen group, regular or occasional publications, information on new products, methods and services. Such activities are carried out by e-mail, fax, SMS, normal post or telephone. The supply of the data for such purposes is optional, and failure to supply them will result in the information not being forwarded.

  1. As far as the creation of your profile on our website, we remind you that your password is strictly confidential and should not be disclosed.
  2. Your data will not be disclosed, but may be shared with individuals, companies, associations or professional studios providing support or consultancy services to the Ibigen Group, the medical sales representative network, our suppliers and any sub-suppliers - from time to time entrusted with activities connected with the above objectives -, mailing or statistical survey companies, or companies for the forwarding of scientific documentation, and individuals authorised to access the data by law and/or pursuant to secondary regulations.
  3. Such people may only acquire knowledge of your personal data for the above mentioned purposes.
  4. The Owners of the Treatment (Data Controllers) are the two companies of the Ibigen Group with legal headquarters at Via Fossignano no. 2, Aprilia (LT), Italy.
  5. Personal data are processed using manual and automated means, for the time necessary for reaching the objectives for which they were collected. Special safety measures are in place to avoid data loss, unlawful or incorrect use and unauthorised access.
  6. Lastly, we also inform you that you can at any time exercise the rights contemplated by the Regulation, and in particular request access to the data, their correction, update and block, or you can withdraw your consent, or request the limitation of the processing or the cancellation of the data. As data subject, you also have the right to issue a complaint with the relevant control Authority. Such rights may be exercised in writing to the following e-mail address: info@ibi-lorenzini.com.
  7. The Data Protection Officer may be contacted at the following e-mail address: dpo_ibi@protectiontrade.it

* Required fields
Cancel